May 06, 2015
OTC Disclosure & News Service
Historic growth in the biotechnology sector is driving a major land grab in the nation’s biotech hub cities, and Taylor Consulting, Inc. (OTCBB:TAYO) is seeking out promising new real estate acquisition opportunities to capitalize on the movement.
A venture capital boom began funneling billions of dollars into life science companies last year, with $8.6 billion invested across the entire life sciences sector. Biotech funding alone jumped to $6 billion, and the Nasdaq biotech index has tripled over the last three years. Now, many experts say that the flood of capital appears poised to continue well into 2015.
With companies large and small in the biotech sector looking to expand their presence in health and science hubs such as Boston, San Francisco and Houston, TAYO is working to add new assets to its portfolio that are primed for redevelopment in the biotech industry.
“Biotech companies are growing so fast that they’re running out of room in their preferred spots,” said TAYO CEO Scott Wheeler. “Vacancy rates are at record lows, and rents have soared. Our company is looking to make smart acquisitions that we can redevelop to ease the overcrowding in the major biotech hot spots.”
Through its real estate division, Third Avenue Development, TAYO is building an emerging portfolio of real estate assets for investment, rehabilitation and resale. The company is focused on acquiring properties in the country’s top-performing housing and real estate markets in order to capitalize on the continued recovery and growth of the U.S. real estate marketplace. For more information, visit www.ThirdAvenueDevelopment.com.
About Taylor Consulting Inc.
Taylor Consulting, Inc. (TAYO) recently created Third Avenue Development, LLC as a new division whose primary goal is to invest in promising real estate assets to compete alongside American Homes 4 Rent (NYSE: AMH), Silver Bay Realty Trust Corp. (NYSE: SBY), Equity Residential (NYSE: EQR), Essex Property Trust Inc. (NYSE: ESS) and others.
Third Avenue Development, a premier hybrid real estate investment and development company, is building an emerging portfolio of real estate assets for investment, rehabilitation and resale. The company is focused on acquiring properties in the country’s top-performing housing markets in order to capitalize on the continued recovery and growth of the U.S. real estate marketplace. For more information, visit www.ThirdAvenueDevelopment.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Copyright © 2015 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Source: otc markets